Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2007
11/15/2007WO2007128555A1 Inhibition of gliotoxin
11/15/2007WO2007128526A2 Combination comprising a vegf inhibitor and a serine protease for treating neovascular diseases
11/15/2007WO2007128493A1 Neuroprotective compounds and uses thereof
11/15/2007WO2007128429A1 Biomarkers for endometrial proliferation
11/15/2007WO2007128222A1 Vitreous administration of erythropoietin
11/15/2007WO2007128121A1 Chimeric pcsk9 proteins, cells comprising same, and assays using same
11/15/2007WO2007128080A1 An assay for modulators of apoptosis
11/15/2007WO2007104646A3 Use of the long pentraxin ptx3 for the prevention or treatment of viral diseases
11/15/2007WO2007100675A3 Collagenase for treating cellulite
11/15/2007WO2007091266A3 Alpha-i antitrypsin for treating exacerbation episodes of pulmonary diseases
11/15/2007WO2007085728A3 Composition containing several botulic toxins
11/15/2007WO2007079753A3 Mutant deoxyadenosine kinase enzymes and their use
11/15/2007WO2007076501A3 Endometriosis cell targeting peptide and uses thereof
11/15/2007WO2007076131A3 Compositions comprising polycation-complexed protein crystals and methods of treatment using them
11/15/2007WO2007069249A3 Toxin-like polypeptides, polynucleotides encoding same and uses thereof
11/15/2007WO2007053792A3 Improving the pharmacokinetics of protease inhibitors and other drugs
11/15/2007WO2007050798A3 Lrrtm1 compositions and methods of their use for the diagnosis and treatment of cancer
11/15/2007WO2007048121A3 Methods of preparing targeted immunoliposomes
11/15/2007WO2007047882A3 Combination of cxcr4 antagonist and morphogen to increase angiogenesis
11/15/2007WO2007044989A3 Modulators of nod1 signaling
11/15/2007WO2007043057A3 Compositions for nasal delivery
11/15/2007WO2007030455A3 Mutations and polymorphisms of hdac10
11/15/2007WO2007022616A8 Hybrid ultrafast laser surgery and growth factor stimulation for ultra-precision surgery with healing
11/15/2007WO2007017259A3 Use of specific trifluoromethyl ketones for preventing and treating pancreatitis
11/15/2007WO2007011682A3 Methods and reagents for screening new drugs and for treating ion pump associated disorders and diseases
11/15/2007WO2006113452A3 Glycoprotein hormone analogs
11/15/2007WO2006083533A3 Compositions and methods for inhibiting drusen formation and for diagnosing or treating drusen-related disorders
11/15/2007WO2006052654A3 Compositions and methods for the treatment of immune mediated diseases
11/15/2007WO2005120564A3 Vaccine compositions and methods
11/15/2007WO2005120549A3 Local delivery of growth factors for stem cell transplantation
11/15/2007WO2005092369A3 Conjugates of hydroxyethyl starch and erythropoietin
11/15/2007WO2005040351A3 Compositions for inducing cell growth and differentiation and methods of using same
11/15/2007WO2005017105A3 Regio- and enantioselective alkane hydroxylation with modified cytochrome p450
11/15/2007WO2004087065A3 Compositions for induction of a therapeutic response
11/15/2007WO2004058988A3 Binding agents which inhibit myostatin
11/15/2007WO2004039961A3 Trefoil domain-containing polypeptides and uses thereof
11/15/2007WO2003106666A3 Protein c variants with altered properties
11/15/2007WO2003090688A3 Enhancement of human epidermal melanogenesis
11/15/2007WO2003086313A3 Methods for lightening skin and hair
11/15/2007WO2003018754A3 Neural regeneration peptide and methods for their use in treatment of brain damage
11/15/2007WO2002068586A3 Hiv/fiv protease inhibitors
11/15/2007WO2001075021A3 A novel polypeptide, glucose transport-associated human protein 10 and the polynucleotide encoding the polypeptide
11/15/2007WO2001055313A3 Nucleic acids, proteins, and antibodies
11/15/2007US20070265331 Such as (2S)-2-(3(S)-Acetylamino-3-((S)-sec-butyl)-2-oxo-pyrrolidin-1-yl)-N-[(1S,2R)-1-(3,5-difluoro-benzyl)-2-hydroxy-3-(3-methoxy-benzylamino)-propyl]-4-phenyl-butyramide; inhibit processing of amyloid precursor proteins
11/15/2007US20070265248 Substituted piperazines and methods of use
11/15/2007US20070265208 Association of calpain inhibitors and reactive oxygen species trapping agents
11/15/2007US20070265207 Treating nocturia, primary nocturnal enuresis, or incontinence, or for inducing voiding postponement; a steady plasma/serum desmopressin concentration in the range of from about 0.1 picograms desmopressin per mL plasma/serum to about 10.0 picogram desmopressin per mL plasma/serum
11/15/2007US20070265206 Cyclic Natriuretic Peptide Constructs
11/15/2007US20070265203 Methods and compositions for modulation of blood-neural barrier
11/15/2007US20070265202 Compounds That Modulate Trh Actions
11/15/2007US20070265201 Inhibitors of inflammatory cytokine transcription derived from hcmv protein ie2
11/15/2007US20070265200 Glycol Linked Fgf-21 Compounds
11/15/2007US20070265199 comprising an A1 domain having a calcium binding site; hemophilia A; antihemophilia agents
11/15/2007US20070265198 Nucleic Acids and Polypeptides of C1 Bacteriophage and Uses Thereof
11/15/2007US20070265196 Method of Modulating Pro-Inflammatory and Inflammatory Activity Mediated by C-Reactive Protein
11/15/2007US20070265195 Multifunctional blood substitute
11/15/2007US20070265194 Agents for the treatment of viral infections
11/15/2007US20070265193 Tetraazabenzo[e]azulene derivatives and analogs thereof
11/15/2007US20070265192 Telechelic Homopolyamino Acids Functionalized with Hydrophobic Groups, and Their Applications, Especially Therapeutic Applications
11/15/2007US20070265191 Pharmaceutical compositions and methods for peptide treatment
11/15/2007US20070265190 Opioid depot formulations
11/15/2007US20070265189 Insulin and igf-1 receptor agonists and antagonists
11/15/2007US20070265188 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
11/15/2007US20070265187 Oral Formulations Comprising Bone Morphogenetic Proteins For Treating Metabolic Bone Diseases
11/15/2007US20070265186 Biotin-Facilitated Transport in Gram Negative Bacteria
11/15/2007US20070264715 Proteins Involved in Signal Transduction
11/15/2007US20070264709 pluripotent cell comprising a sequence encoding a selectable marker operatively linked to a promoter of a gene selected from the group consisting of sox-1, sox-2, sox-3, Pax 3, delta-1, Mash-1, Math 4a, Pax 6, beta 3-tubulin, synapsin-1, MAP2/tau, GFAP, GABA and islet-1/2
11/15/2007US20070264686 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide; cancer treatment
11/15/2007US20070264669 Compositions and methods for the enhancement of soluble amyloid beta oligomer (ADDL) uptake and clearance
11/15/2007US20070264359 administering an effective amount of an aqueous or alcohol extract of Phyllanthus to a mammal infected with the YMDD hepatitis B virus mutant strain resistant; inhibiting viral gene expression in a mammal infected with a hepatitis B virus
11/15/2007US20070264351 Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
11/15/2007US20070264343 Methods for making and using particulate pharmaceutical formulations for sustained release
11/15/2007US20070264336 Hydrophilic/lipophilic polymeric matrix dosage formulation
11/15/2007US20070264321 Method of treating skin wounds with vectors encoding hepatocyte growth factor
11/15/2007US20070264311 Cysteine Protease from Ginger (Zingiber) as a Food Improver and Anti-Inflammatory
11/15/2007US20070264306 Scaffold engineering
11/15/2007US20070264290 Pharmaceutical and/or Cosmetic Care Product, Such as a Mask
11/15/2007US20070264284 Therapeutic, Prophylactic and Diagnostic Agents for Hepatitis B
11/15/2007US20070264282 Herpes virus strains for gene therapy
11/15/2007US20070264280 Compositions and Methods for Treating Neurological Diseases
11/15/2007US20070264277 Compositions and Methods of Use for Mgd-Csf in Disease Treatment
11/15/2007US20070264275 Peptides Derived from the Protein Mmp-2, and the Use Thereof in Antitumoral Immunotherapy
11/15/2007US20070264273 Sphingoid polyalklamine conjugates, isomers and uses thereof
11/15/2007US20070264261 Methods of Therapy and Diagnosis Using Targeting of Cells that Express Killer Cell Immunoglobulin like Receptor like Proteins
11/15/2007US20070264259 Methods for treating kidney disorders
11/15/2007US20070264256 polynucleotide sequence of a NTHi, polypeptides encoded by it and antibodies that bind to the polypeptide; detecting NTHi bacteria in a biological sample by contacting a polynucleotide to detect hybridization of the polynucleotide
11/15/2007US20070264254 Cardiac muscle function and manipulation
11/15/2007US20070264252 Modulators of Ms4a Gene Products
11/15/2007US20070264250 Composition for Skin-Whitening and Wrinkle-Care
11/15/2007US20070264249 Gene-based lipid hydrolysis therapy for atherosclerosis and related diseases
11/15/2007US20070264248 Preparation for preventing or treating disorders caused by toxic constituents contained in fiber combustion smoke
11/15/2007US20070264247 Use of Human Lysozyme in Preparation of Medicine for Treating Acne
11/15/2007US20070264246 ENHANCED MEDICAL TREATMENTS RESULTING FROM CHEMICAL IDENTIFICATION OF CALCIUM INFLUX FACTOR, IDENTITY WITH THE FACTOR ACTIVATING PHOSPHOLIPOLYSIS AND PRECIPITATING SUDDEN DEATH DURING MYOCARDIAL INFARCTION, AND DETERMINATION OF SIMILAR ACTIVATING MECHANISMS IN MULTIPLE CELL TYPES THROUGH DISINHIBITION OF CALCIUM-INDEPENDENT PHOSPHOLIPASE A2beta
11/15/2007US20070264245 Compositions and minimally invasive methods for treating incomplete tissue repair
11/15/2007US20070264244 Pigment epithelial cell of the eye, its production and use in therapy of an eye or CNS disease
11/15/2007US20070264241 Compounds for Enhanced Cancer Therapy
11/15/2007US20070264240 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formation
11/15/2007US20070264237 Use of Il-18 Binding Protein in Inflammations
11/15/2007US20070264236 Novel Therapeutic Fusion Proteins
11/15/2007US20070264235 Polypeptide Having an Improved Cytosine Deaminase Activity
1 ... 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 ... 3163